Download PDF
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2013; 34(03): 186-188
DOI: 10.4103/0971-5851.123728
ORIGINAL ARTICLE

A short report on chronic myeloid leukemia from Post Graduate Institute of Medical Education and Research, Chandigarh

Pankaj Malhotra
Department of Internal Medicine and Hematology, Post Graduate Institute, Chandigarh, India
,
Neelam Varma
Department of Internal Medicine and Hematology, Post Graduate Institute, Chandigarh, India
,
Subhash Varma
Department of Internal Medicine and Hematology, Post Graduate Institute, Chandigarh, India
› Author Affiliations
› Further Information
  PDF Download Permissions and Reprints

Abstract

Post Graduate Institute (PGI) Chandigarh is a premier institute of North India. There are approximately 70,000 admissions per year. The adult clinical hematology department sees more than 2000 new patients per year. A preliminary analysis of 299 chronic myeloid leukemia patients registered from January 2001 until December 2007 was done. Out of these, 256 (86%) patients were in chronic phase (CP). The median age at presentation was 40 years. At 6 months of follow-up 95% of patients who were started on Imatinib mesylate based therapy remained in CP. Partial cytogenetic remission was seen in 69% of patients while complete cytogenetic response was seen in only 20% of patients at 6 months on Imatinib mesylate.

Keywords

Chronic myeloid leukemia - chronic phase - Post Graduate Institute


Publication History

Article published online:
19 July 2021

© 2013. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Malhotra P, Varma S. Chronic myeloid leukaemia in India. Lancet 2007;370:1127.
  • 2 Bhutani M, Vora A, Kumar L, Kochupillai V. Lympho-hemopoietic malignancies in India. Med Oncol 2002;19:141-50.
  • 3 National Cancer Registry Programme. Two Year Report of the Population Based Cancer Registries 1999-2000. New Delhi: Indian Council of Medical Research; 2005.
  • 4 Anand MS, Varma N, Varma S, Rana KS, Malhotra P. Cytogenetic & molecular analyses in adult chronic myelogenous leukaemia patients in north India. Indian J Med Res. 2012;135:42-8.
  • 5 Deininger MW, O′Brien SG, Ford JM, Druker BJ. Practical management of patients with chronic myeloid leukemia receiving imatinib. J Clin Oncol 2003;21:1637-47.